With the notion of science above everything else, a strong tumor research team has been formed, combined with the academic background and interests of the scientists, and concentrated on tackling key tumor science and clinical core issues.

The Institute of Neurological and Psychiatric Disorders aims to understand pathogenic mechanisms of brain disorders including Alzheimer's disease, autism, chronic pain, depression, sleep disorder, schizophrenia, and stroke. The Institute encourages collaborations among scientists and clinicians with expertise in neuroscience, chemistry, engineering, computer science and medicine. With a better understanding of disease mechanisms, we hope to develop new ways to diagnose and treat neurological and psychiatric disorders

The Institute of Infectious Diseases in Shenzhen Bay Laboratory was established in August 2020. Positioned at the intersection of basic research, public health, and clinical studies, this pioneering institute is devoted to shaping foundational theories and spearheading the development of novel vaccines and therapeutic drugs.

The Institute of Systems and Physical Biology of Shenzhen Bay Laboratory is dedicated to basic biomedical research, focusing on fundamental systems biology challenges by interdisciplinary collaborations broadly covering genomics and epigenetics, protein drug design, protein engineering and enzyme catalysis, signal transduction, bioinformatics and artificial intelligence, metabolic control, and photobiology.

Molecular biology explores the nature of life based on its ever-expanding understanding to the genetic central dogma of biology and promotes technologies that can be widely applied in life sciences.

The Institute of Chemical Biology (ICB) at Shenzhen Bay Laboratory is committed to integrating the scientific principles and methodologies of chemistry, biology, and related disciplines to understand and manipulate biological systems at the molecular level.

The Biomedical Engineering Research Institute will focus on building a healthy China and the Guangdong-Hong Kong-Macao Greater Bay Area International Scientific and Technological Innovation Center, promoting Shenzhen's national strategy of building a world-class life information and biomedical innovation city, and will gather a group of elites with international vision and innovative capabilities Scientists and engineers and technicians have built world-class research platforms and innovation systems. Through carrying out multidisciplinary research, several world-class major original results have been obtained.

Pingshan Translational Medicine Center focuses on the research of frontier innovative drugs, promotes cooperation between research institutions and the industry, accelerates the transformation of core new technologies, attracts and serves enterprises throughout the industrial chain, incubates biomedical technology companies, forms a biomedical ecosystem driven by core technologies, and propels innovation in treatments for major diseases.

TIC is the pioneer of achievement transformation at Shenzhen Bay Laboratory. The center focuses on areas such as neurological diseases, metabolic/cardiovascular diseases, tumors/immune system diseases, and pays attention to unmet clinical needs. It cooperates with cutting-edge basic research experts and clinical experts to carry out new drug conversion research from frontier basic research to preclinical (macromolecular/small molecule) stages.